-
1
-
-
0029121769
-
Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
-
Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA, (1995) Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76: 1197-1200.
-
(1995)
Cancer
, vol.76
, pp. 1197-1200
-
-
Page, D.L.1
Dupont, W.D.2
Rogers, L.W.3
Jensen, R.A.4
Schuyler, P.A.5
-
2
-
-
2942672535
-
Ductal carcinoma in situ, complexities and challenges
-
Leonard GD, Swain SM, (2004) Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 96: 906-920.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 906-920
-
-
Leonard, G.D.1
Swain, S.M.2
-
3
-
-
50949096353
-
Recent advances and current controversies in the management of DCIS of the breast
-
Sakorafas GH, Farley DR, Peros G, (2008) Recent advances and current controversies in the management of DCIS of the breast. Cancer Treat Rev 34: 483-497.
-
(2008)
Cancer Treat Rev
, vol.34
, pp. 483-497
-
-
Sakorafas, G.H.1
Farley, D.R.2
Peros, G.3
-
4
-
-
33746811910
-
Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853--A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group
-
Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, et al. (2006) Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853--A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24: 3381-3387.
-
(2006)
J Clin Oncol
, vol.24
, pp. 3381-3387
-
-
Bijker, N.1
Meijnen, P.2
Peterse, J.L.3
Bogaerts, J.4
Van Hoorebeeck, I.5
-
5
-
-
0035499267
-
Stem cells, cancer, and cancer stem cells
-
Reya T, Morrison SJ, Clarke MF, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
-
(2001)
Nature
, vol.414
, pp. 105-111
-
-
Reya, T.1
Morrison, S.J.2
Clarke, M.F.3
Weissman, I.L.4
-
6
-
-
0037388204
-
Prospective identification of tumorigenic breast cancer cells
-
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
-
(2003)
Proc Natl Acad Sci U S A
, vol.100
, pp. 3983-3988
-
-
Al-Hajj, M.1
Wicha, M.S.2
Benito-Hernandez, A.3
Morrison, S.J.4
Clarke, M.F.5
-
7
-
-
33845904383
-
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation
-
Phillips TM, McBride WH, Pajonk F, (2006) The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777-1785.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 1777-1785
-
-
Phillips, T.M.1
McBride, W.H.2
Pajonk, F.3
-
8
-
-
44049100934
-
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
-
Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, et al. (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100: 672-679.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 672-679
-
-
Li, X.1
Lewis, M.T.2
Huang, J.3
Gutierrez, C.4
Osborne, C.K.5
-
9
-
-
33845874094
-
Cancer stem cells and radiotherapy: new insights into tumor radioresistance
-
Diehn M, Clarke MF, (2006) Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J Natl Cancer Inst 98: 1755-1757.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 1755-1757
-
-
Diehn, M.1
Clarke, M.F.2
-
10
-
-
34247581697
-
Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways
-
Farnie G, Clarke RB, Spence K, Pinnock N, Brennan K, et al. (2007) Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst 99: 616-627.
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 616-627
-
-
Farnie, G.1
Clarke, R.B.2
Spence, K.3
Pinnock, N.4
Brennan, K.5
-
11
-
-
50649125794
-
ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor
-
Osipo C, Patel P, Rizzo P, Clementz AG, Hao L, et al. (2008) ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor. Oncogene 27: 5019-5032.
-
(2008)
Oncogene
, vol.27
, pp. 5019-5032
-
-
Osipo, C.1
Patel, P.2
Rizzo, P.3
Clementz, A.G.4
Hao, L.5
-
12
-
-
80052494506
-
Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
-
Pandya K, Meeke K, Clementz AG, Rogowski A, Roberts J, et al. (2011) Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence. Br J Cancer 105: 796-806.
-
(2011)
Br J Cancer
, vol.105
, pp. 796-806
-
-
Pandya, K.1
Meeke, K.2
Clementz, A.G.3
Rogowski, A.4
Roberts, J.5
-
13
-
-
77954351997
-
Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer
-
Dong Y, Li A, Wang J, Weber JD, Michel LS, (2010) Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer. Cancer Res 70: 5465-5474.
-
(2010)
Cancer Res
, vol.70
, pp. 5465-5474
-
-
Dong, Y.1
Li, A.2
Wang, J.3
Weber, J.D.4
Michel, L.S.5
-
14
-
-
67449116604
-
Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells
-
Meurette O, Stylianou S, Rock R, Collu GM, Gilmore AP, et al. (2009) Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells. Cancer Res 69: 5015-5022.
-
(2009)
Cancer Res
, vol.69
, pp. 5015-5022
-
-
Meurette, O.1
Stylianou, S.2
Rock, R.3
Collu, G.M.4
Gilmore, A.P.5
-
15
-
-
84857112420
-
Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling
-
Pradeep CR, Kostler WJ, Lauriola M, Granit RZ, Zhang F, et al. (2011) Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling. Oncogene 31(7): 907-917.
-
(2011)
Oncogene
, vol.31
, Issue.7
, pp. 907-917
-
-
Pradeep, C.R.1
Kostler, W.J.2
Lauriola, M.3
Granit, R.Z.4
Zhang, F.5
-
16
-
-
0034854417
-
ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini
-
Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS, (2001) ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol 3: 785-792.
-
(2001)
Nat Cell Biol
, vol.3
, pp. 785-792
-
-
Muthuswamy, S.K.1
Li, D.2
Lelievre, S.3
Bissell, M.J.4
Brugge, J.S.5
-
17
-
-
76549084826
-
Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor
-
Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, et al. (2010) Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res 70: 709-718.
-
(2010)
Cancer Res
, vol.70
, pp. 709-718
-
-
Harrison, H.1
Farnie, G.2
Howell, S.J.3
Rock, R.E.4
Stylianou, S.5
-
18
-
-
62549096930
-
Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab
-
Magnifico A, Albano L, Campaner S, Delia D, Castiglioni F, et al. (2009) Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab. Clin Cancer Res 15: 2010-2021.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 2010-2021
-
-
Magnifico, A.1
Albano, L.2
Campaner, S.3
Delia, D.4
Castiglioni, F.5
-
19
-
-
78650248243
-
Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation
-
Grudzien P, Lo S, Albain KS, Robinson P, Rajan P, et al. (2010) Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Anticancer Res 30: 3853-3867.
-
(2010)
Anticancer Res
, vol.30
, pp. 3853-3867
-
-
Grudzien, P.1
Lo, S.2
Albain, K.S.3
Robinson, P.4
Rajan, P.5
-
20
-
-
54049096261
-
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
-
Korkaya H, Paulson A, Iovino F, Wicha MS, (2008) HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 27: 6120-6130.
-
(2008)
Oncogene
, vol.27
, pp. 6120-6130
-
-
Korkaya, H.1
Paulson, A.2
Iovino, F.3
Wicha, M.S.4
|